Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

Mean body weight reduction in the three highest dose groups (3.5 mg-6 mg) reached about 3%, compared to about 1% weight gain ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like Jardiance ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

The drug suppresses appetite and promotes satiety, possibly leading to weight loss. Once you stop taking it, however, you’re likely to gain some of ... like peptide-1 (GLP-1) receptor agonist ...

That’s why, alongside The Asda Foundation, we’re proud to invest almost £1 million through our in-store initiatives and grants to do what we can to tackle loneliness and isolation in the communities ...

“We’re starting to see that GLP-1 receptor agonists, like Ozempic, may have anti-inflammatory effects,” he said, “which could help with knee pain beyond weight loss alone.” Singh said ...

Vision Fund 2, which houses a broader roster of early stage tech startups, suffered an investment loss of US$1.7 billion for the quarter. While Vision Fund one has had a gross gain of US$22.6 billion ...

Researchers at Baylor College of Medicine, Stanford University School of Medicine and collaborating institutions report in ...